Drugs Made In America Acquisition Corp. 8-K

What Happened
Drugs Made In America Acquisition Corp. filed a Form 8-K on March 6, 2026 reporting that an affiliate (Drugs Made In America Acquisition II Corp.) experienced improper withdrawals by its sponsor between the affiliate’s IPO closing on September 26, 2025 and December 31, 2025. The company’s board investigated and confirmed these irregularities did not affect the Company’s trust account; as of March 6, 2026 the Trust Account holds approximately $241,292,436.

Key Details

• Affiliate involved: Drugs Made In America Acquisition II Corp.; improper withdrawals occurred between Sept. 26, 2025 and Dec. 31, 2025.
• Responsible party: sponsor to the affiliate (described in the filing as having made the “Irregularities”).
• Trust Account balance confirmed: approximately $241,292,436 as of March 6, 2026.
• Disclosure made via Current Report on Form 8-K filed March 6, 2026 (Item 8.01, Other Events).

Why It Matters
For investors, the filing confirms the company’s main trust account — typically used to hold IPO proceeds for potential deals — was not impacted by the affiliate sponsor’s improper withdrawals. The specific, confirmed trust balance provides transparency about available funds and reduces immediate uncertainty tied to the reported affiliate irregularities.